1. Home
  2. NUVL vs FSS Comparison

NUVL vs FSS Comparison

Compare NUVL & FSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$105.83

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Logo Federal Signal Corporation

FSS

Federal Signal Corporation

HOLD

Current Price

$112.46

Market Cap

6.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUVL
FSS
Founded
2017
1901
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
6.9B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
NUVL
FSS
Price
$105.83
$112.46
Analyst Decision
Strong Buy
Hold
Analyst Count
15
4
Target Price
$135.00
$127.33
AVG Volume (30 Days)
548.0K
378.7K
Earning Date
02-26-2026
02-25-2026
Dividend Yield
N/A
0.49%
EPS Growth
N/A
10.74
EPS
N/A
3.82
Revenue
N/A
$2,055,400,000.00
Revenue This Year
N/A
$15.50
Revenue Next Year
N/A
$15.77
P/E Ratio
N/A
$29.98
Revenue Growth
N/A
11.83
52 Week Low
$55.54
$66.47
52 Week High
$112.88
$132.89

Technical Indicators

Market Signals
Indicator
NUVL
FSS
Relative Strength Index (RSI) 54.70 46.67
Support Level $97.43 $110.88
Resistance Level $108.65 $119.42
Average True Range (ATR) 4.95 2.75
MACD 0.48 0.05
Stochastic Oscillator 82.96 40.16

Price Performance

Historical Comparison
NUVL
FSS

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

About FSS Federal Signal Corporation

Federal Signal Corp designs and manufactures products and integrated solutions for municipal, governmental, industrial, and airport customers. It operates in the segments of Environmental Solutions Group and the Safety and Security Systems Group. The Environmental Solutions group manufactures and supplies street sweeper vehicles, sewer cleaner and vacuum loader trucks, hydro-excavation trucks, high-performance water blasting equipment, dump truck bodies, and trailers. The Safety and Security Systems Group offers comprehensive systems and products such as campus and community alerting, emergency vehicles, first responder interoperable communications, and others. The company generates a majority of its revenue from the Environmental Solutions Group segment.

Share on Social Networks: